These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33974659)

  • 1. Rates of protein synthesis are reduced in peripheral blood mononuclear cells (PBMCs) from fragile X individuals.
    Dionne O; Lortie A; Gagnon F; Corbin F
    PLoS One; 2021; 16(5):e0251367. PubMed ID: 33974659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new strategy to uncover fragile X proteomic biomarkers using the nascent proteome of peripheral blood mononuclear cells (PBMCs).
    Dionne O; Corbin F
    Sci Rep; 2021 Jul; 11(1):15148. PubMed ID: 34312401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional rates of brain protein synthesis are unaltered in dexmedetomidine sedated young men with fragile X syndrome: A L-[1-
    Schmidt KC; Loutaev I; Quezado Z; Sheeler C; Smith CB
    Neurobiol Dis; 2020 Sep; 143():104978. PubMed ID: 32569795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelets as a surrogate disease model of neurodevelopmental disorders: Insights from Fragile X Syndrome.
    Pellerin D; Lortie A; Corbin F
    Platelets; 2018 Mar; 29(2):113-124. PubMed ID: 28660769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein synthesis levels are increased in a subset of individuals with fragile X syndrome.
    Jacquemont S; Pacini L; Jønch AE; Cencelli G; Rozenberg I; He Y; D'Andrea L; Pedini G; Eldeeb M; Willemsen R; Gasparini F; Tassone F; Hagerman R; Gomez-Mancilla B; Bagni C
    Hum Mol Genet; 2018 Jun; 27(12):2039-2051. PubMed ID: 29590342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ICAM5 as a Novel Target for Treating Cognitive Impairment in Fragile X Syndrome.
    Pei YP; Wang YY; Liu D; Lei HY; Yang ZH; Zhang ZW; Han M; Cheng K; Chen YS; Li JQ; Cheng GR; Xu L; Wu QM; McClintock SM; Yang Y; Zhang Y; Zeng Y
    J Neurosci; 2020 Feb; 40(6):1355-1365. PubMed ID: 31882402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of GpI mGluR-Dependent Cav2.3 Translation in a Mouse Model of Fragile X Syndrome.
    Gray EE; Murphy JG; Liu Y; Trang I; Tabor GT; Lin L; Hoffman DA
    J Neurosci; 2019 Sep; 39(38):7453-7464. PubMed ID: 31350260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective Deletion of Astroglial FMRP Dysregulates Glutamate Transporter GLT1 and Contributes to Fragile X Syndrome Phenotypes In Vivo.
    Higashimori H; Schin CS; Chiang MS; Morel L; Shoneye TA; Nelson DL; Yang Y
    J Neurosci; 2016 Jul; 36(27):7079-94. PubMed ID: 27383586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excess protein synthesis in FXS patient lymphoblastoid cells can be rescued with a p110β-selective inhibitor.
    Gross C; Bassell GJ
    Mol Med; 2012 May; 18(1):336-45. PubMed ID: 22207187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and cellular aspects of mental retardation in the Fragile X syndrome: from gene mutation/s to spine dysmorphogenesis.
    De Rubeis S; Fernández E; Buzzi A; Di Marino D; Bagni C
    Adv Exp Med Biol; 2012; 970():517-51. PubMed ID: 22351071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.
    Sheridan SD; Theriault KM; Reis SA; Zhou F; Madison JM; Daheron L; Loring JF; Haggarty SJ
    PLoS One; 2011; 6(10):e26203. PubMed ID: 22022567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine-Derived Epithelial Cell Lines: A New Tool to Model Fragile X Syndrome (FXS).
    Zafarullah M; Jasoliya M; Tassone F
    Cells; 2020 Oct; 9(10):. PubMed ID: 33027907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FMRP Levels in Human Peripheral Blood Leukocytes Correlates with Intellectual Disability.
    Roth M; Ronco L; Cadavid D; Durbin-Johnson B; Hagerman RJ; Tassone F
    Diagnostics (Basel); 2021 Sep; 11(10):. PubMed ID: 34679478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synaptic vesicle dynamic changes in a model of fragile X.
    Broek JAC; Lin Z; de Gruiter HM; van 't Spijker H; Haasdijk ED; Cox D; Ozcan S; van Cappellen GWA; Houtsmuller AB; Willemsen R; de Zeeuw CI; Bahn S
    Mol Autism; 2016; 7():17. PubMed ID: 26933487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of fragile X syndrome specific molecular markers in human fibroblasts: a useful model to test the efficacy of therapeutic drugs.
    Kumari D; Bhattacharya A; Nadel J; Moulton K; Zeak NM; Glicksman A; Dobkin C; Brick DJ; Schwartz PH; Smith CB; Klann E; Usdin K
    Hum Mutat; 2014 Dec; 35(12):1485-94. PubMed ID: 25224527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragile X Mental Retardation Protein Is Required to Maintain Visual Conditioning-Induced Behavioral Plasticity by Limiting Local Protein Synthesis.
    Liu HH; Cline HT
    J Neurosci; 2016 Jul; 36(27):7325-39. PubMed ID: 27383604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The translation of translational control by FMRP: therapeutic targets for FXS.
    Darnell JC; Klann E
    Nat Neurosci; 2013 Nov; 16(11):1530-6. PubMed ID: 23584741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. R-Baclofen Reverses a Social Behavior Deficit and Elevated Protein Synthesis in a Mouse Model of Fragile X Syndrome.
    Qin M; Huang T; Kader M; Krych L; Xia Z; Burlin T; Zeidler Z; Zhao T; Smith CB
    Int J Neuropsychopharmacol; 2015 Mar; 18(9):. PubMed ID: 25820841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragile X Mental Retardation Protein (FMRP) controls diacylglycerol kinase activity in neurons.
    Tabet R; Moutin E; Becker JA; Heintz D; Fouillen L; Flatter E; Krężel W; Alunni V; Koebel P; Dembélé D; Tassone F; Bardoni B; Mandel JL; Vitale N; Muller D; Le Merrer J; Moine H
    Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3619-28. PubMed ID: 27233938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced serum levels of pro-inflammatory chemokines in fragile X syndrome.
    Van Dijck A; Barbosa S; Bermudez-Martin P; Khalfallah O; Gilet C; Martinuzzi E; Elinck E; Kooy RF; Glaichenhaus N; Davidovic L
    BMC Neurol; 2020 Apr; 20(1):138. PubMed ID: 32295518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.